advanced heart failure (AHF) referred for consideration of ventricular assist device (VAD) implantation and/or heart transplantation (HTx).
TRANSITIONAL STATES IN FRAILTY: IMPLICATIONS FOR END OF LIFE SUPPORT IN HEART FAILURE
The frailty syndrome is defined as the loss of reserve in multiple physiological systems that occur with ageing. Frailty can result in vulnerability to any minor disturbances and exposes older adults to an array of adverse health outcomes such as falls, fractures, hospitalisations, and mortality. The most common phenotype associated with frailty is sarcopenia, the agerelated loss of skeletal muscle mass and function. The heart is a muscular structure, yet we do not understand whether the decline in cardiac function in old age is directly related to sarcopenia. However, there has recently been increasing interests in the correlation between heart failure and frailty status. Moreover, frailty is a reversible process. Overseas and local data have confirmed that up to a quarter of those in the prefrail status can revert to the robust state. This presentation is focused on the evidence in reversing frailty, and examines options in improving the function of older heart failure patients. It is well documented that implantable cardioverter defibrillator (ICD) saves lives in populations at risk for sudden death. However, mortality in advanced heart failure remains high despite advances in therapy.
1 Twenty per cent of ICD patients receiving shocks in the final weeks of their lives experience pain and decreased quality of life, causing distress to patients and their families. 2 Ethically and legally, there are no differences between refusing ICD therapy and requesting withdrawal of ICD therapy. Carrying out a request to withdraw life-sustaining treatment is neither physician-assisted suicide nor euthanasia. 3 Decisions about deactivation of ICD are complicated. Proactive communication by clinicians before implant and during device follow-up are important in order to minimise suffering as the end of life nears for patients with ICDs. Clear discussion about the benefits and burdens of the device should be made. Advance care planning addressing device deactivation should be encouraged for all patients with ICD. 4 Advanced cardiac diseases are common non-cancer conditions that require good palliative care. Palliative Care should embrace both cancer and non-cancer conditions, and is applicable early in the course of illness, in conjunction with other therapies. There is a high prevalence of symptoms and distress in heat failure (HF) necessitating palliative care, which include not just dyspnoea and oedema but also a range of other symptoms that are all sub-optimally controlled at the end of life.
